ClinicalTrials.Veeva

Menu

Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10

F

Finnish Institute for Health and Welfare

Status

Completed

Conditions

Pneumococcal Infections

Treatments

Biological: 10-valent pneumococcal conjugate vaccine, PCV10

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04912297
THL/1019/6.00.00/2017

Details and patient eligibility

About

The aim of the study are to assess the persistence of immunity against vaccine serotypes (VSTs) and vaccine-related serotypes in PCV10 vaccinated children in Finland.

Full description

The primary objective is to evaluate the long-term persistence of humoral immunity to vaccine-related pneumococcal serotypes after vaccination with PCV10.

Enrollment

186 patients

Sex

All

Ages

13 months to 3 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Completed PCV10 vaccination with 3 or 4 doses (2+1 or 3+1 schedule) before blood sampling at age of 13 months
  • Age at sample collection 13 months, 2 years or 3 years
  • PCV10 vaccination received 2-6 weeks before sample collection at the age of 1 year
  • Informed consent obtained covering the planned analyses

Exclusion criteria

  • PCV13 or PPV23 dose received
  • Informed consent withdrawn

Trial design

186 participants in 2 patient groups

PCV10 2+1 schedule
Description:
Ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10; GlaxoSmithKline) administered with a 2+1 schedule (two vaccinations with minimum 8-week intervals followed by a booster dose at least 4 months after the last primary dose).
Treatment:
Biological: 10-valent pneumococcal conjugate vaccine, PCV10
PCV10 3+1 schedule
Description:
Ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10; GlaxoSmithKline) administered with a 3+1 schedule (three vaccinations with minimum 4-week intervals, followed by a booster dose at least 4 months after the last primary dose).
Treatment:
Biological: 10-valent pneumococcal conjugate vaccine, PCV10

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems